Deranged neuronal calcium signaling and Huntington disease

Biochemical and Biophysical Research Communications

Volumn 322, Issue 4, 2004, Pages 1310-1317

  Bezprozvanny, Ilya ^a   Hayden, Michael R ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Kinsmen Lab Neurol Res Brain R   (Canada)

Author keywords

Apoptosis; Calcium signaling; Huntingtin; Inositol 1,4,5 trisphosphate; Mitochondria; Neurodegeneration; NMDA; Polyglutamine expansion

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; HUNTINGTIN; INOSITOL 1,4,5 TRISPHOSPHATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYGLUTAMINE; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BRAIN; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; LIPID BILAYER; LYMPHOBLAST; MITOCHONDRION; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SENSITIZATION;

SPINY;

EID: 4444302167     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.08.035     Document Type: Article

References (61)

1. J.P. Vonsattel, and M. DiFiglia Huntington disease J. Neuropathol. Exp. Neurol. 57 1998 369 384
2. J.P. Vonsattel, R.H. Myers, T.J. Stevens, R.J. Ferrante, E.D. Bird, and E.P. Richardson Jr. Neuropathological classification of Huntington's disease J. Neuropathol. Exp. Neurol. 44 1985 559 577
3. The Huntington's Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell 72 (1993) 971-983
4. D.R. Langbehn, R.R. Brinkman, D. Falush, J.S. Paulsen, and M.R. Hayden A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length Clin. Genet. 65 2004 267 277
5. S.H. Li, G. Schilling, W.S. Young 3rd, X.J. Li, R.L. Margolis, O.C. Stine, M.V. Wagster, M.H. Abbott, M.L. Franz, and N.G. Ranen Huntington's disease gene (IT15) is widely expressed in human and rat tissues Neuron 11 1993 985 993
6. T.V. Strong, D.A. Tagle, J.M. Valdes, L.W. Elmer, K. Boehm, M. Swaroop, K.W. Kaatz, F.S. Collins, and R.L. Albin Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues Nat. Genet. 5 1993 259 265
7. A.H. Sharp, S.J. Loev, G. Schilling, S.H. Li, X.J. Li, J. Bao, M.V. Wagster, J.A. Kotzuk, J.P. Steiner, and A. Lo Widespread expression of Huntington's disease gene (IT15) protein product Neuron 14 1995 1065 1074
8. J. Nasir, S.B. Floresco, J.R. O'Kusky, V.M. Diewert, J.M. Richman, J. Zeisler, A. Borowski, J.D. Marth, A.G. Phillips, and M.R. Hayden Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes Cell 81 1995 811 823
9. M.P. Duyao, A.B. Auerbach, A. Ryan, F. Persichetti, G.T. Barnes, S.M. McNeil, P. Ge, J.P. Vonsattel, J.F. Gusella, and A.L. Joyner Inactivation of the mouse Huntington's disease gene homolog Hdh Science 269 1995 407 410
10. M.E. MacDonald, Huntingtin: alive and well and working in middle management, Sci. STKE 2003 (2003) pe48
11. D.C. Rubinsztein Lessons from animal models of Huntington's disease Trends Genet. 18 2002 202 209
12. L.B. Menalled, and M.F. Chesselet Mouse models of Huntington's disease Trends Pharmacol. Sci. 23 2002 32 39
13. A.J. Tobin, and E.R. Signer Huntington's disease: the challenge for cell biologists Trends Cell Biol. 10 2000 531 536
14. C.A. Ross Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders Neuron 35 2002 819 822
15. P. Harjes, and E.E. Wanker The hunt for huntingtin function: interaction partners tell many different stories Trends Biochem. Sci. 28 2003 425 433
16. K.L. Sugars, and D.C. Rubinsztein Transcriptional abnormalities in Huntington disease Trends Genet. 19 2003 233 238
17. S.H. Li, and X.J. Li Huntingtinâ€"protein interactions and the pathogenesis of Huntington's disease Trends Genet. 20 2004 146 154
18. M. Gu, M.T. Gash, V.M. Mann, F. Javoy-Agid, J.M. Cooper, and A.H. Schapira Mitochondrial defect in Huntington's disease caudate nucleus Ann. Neurol. 39 1996 385 389
19. S.E. Browne, A.C. Bowling, U. MacGarvey, M.J. Baik, S.C. Berger, M.M. Muqit, E.D. Bird, and M.F. Beal Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia Ann. Neurol. 41 1997 646 653
20. S.J. Tabrizi, M.W. Cleeter, J. Xuereb, J.W. Taanman, J.M. Cooper, and A.H. Schapira Biochemical abnormalities and excitotoxicity in Huntington's disease brain Ann. Neurol. 45 1999 25 32
21. S.J. Tabrizi, J. Workman, P.E. Hart, L. Mangiarini, A. Mahal, G. Bates, J.M. Cooper, and A.H. Schapira Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse Ann. Neurol. 47 2000 80 86
22. E. Carafoli Historical review: mitochondria and calcium: ups and downs of an unusual relationship Trends Biochem. Sci. 28 2003 175 181
23. 2+ liaison, Sci STKE 2004 (2004) re1
24. A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, W.J. Strittmatter, and J.T. Greenamyre Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat. Neurosci. 5 2002 731 736
25. J.G. Hodgson, N. Agopyan, C.A. Gutekunst, B.R. Leavitt, F. LePiane, R. Singaraja, D.J. Smith, N. Bissada, K. McCutcheon, J. Nasir, L. Jamot, X.J. Li, M.E. Stevens, E. Rosemond, J.C. Roder, A.G. Phillips, E.M. Rubin, S.M. Hersch, and M.R. Hayden A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 23 1999 181 192
26. C.A. Gutekunst, S.H. Li, H. Yi, R.J. Ferrante, X.J. Li, S.M. Hersch, and The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human J. Neurosci. 18 1998 7674 7686
27. J.T. Coyle, and R. Schwarcz Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea Nature 263 1976 244 246
28. E.G. McGeer, and P.L. McGeer Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids Nature 263 1976 517 519
29. E.G. McGeer, P.L. McGeer, and K. Singh Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract Brain Res. 139 1978 381 383
30. M.F. Beal, N.W. Kowall, D.W. Ellison, M.F. Mazurek, K.J. Swartz, and J.B. Martin Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 1986 168 171
31. P. Hantraye, D. Riche, M. Maziere, and O. Isacson A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon Exp. Neurol. 108 1990 91 104
32. M.F. Beal, R.J. Ferrante, K.J. Swartz, and N.W. Kowall Chronic quinolinic acid lesions in rats closely resemble Huntington's disease J. Neurosci. 11 1991 1649 1659
33. N. Chen, T. Luo, C. Wellington, M. Metzler, K. McCutcheon, M.R. Hayden, and L.A. Raymond Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin J. Neurochem. 72 1999 1890 1898
34. M.M. Zeron, N. Chen, A. Moshaver, A.T. Lee, C.L. Wellington, M.R. Hayden, and L.A. Raymond Mutant huntingtin enhances excitotoxic cell death Mol. Cell. Neurosci. 17 2001 41 53
35. G.B. Landwehrmeyer, D.G. Standaert, C.M. Testa, J.B. Penney Jr., and A.B. Young NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum J. Neurosci. 15 1995 5297 5307
36. H. Monyer, N. Burnashev, D.J. Laurie, B. Sakmann, and P.H. Seeburg Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 1994 529 540
37. C. Portera-Cailliau, D.L. Price, and L.J. Martin N-methyl-d-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies J. Neurochem. 66 1996 692 700
38. M.M. Zeron, O. Hansson, N. Chen, C.L. Wellington, B.R. Leavitt, P. Brundin, M.R. Hayden, and L.A. Raymond Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease Neuron 33 2002 849 860
39. M.M. Zeron, H.B. Fernandes, C. Krebs, J. Shehadeh, C.L. Wellington, B.R. Leavitt, K.G. Baimbridge, M.R. Hayden, and L.A. Raymond Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease Mol. Cell. Neurosci. 25 2004 469 479
40. Y. Sun, A. Savanenin, P.H. Reddy, and Y.F. Liu Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95 J. Biol. Chem. 276 2001 24713 24718
41. D.W. Ali, and M.W. Salter NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity Curr. Opin. Neurobiol. 11 2001 336 342
42. C. Song, Y. Zhang, C.G. Parsons, and Y.F. Liu Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-d-aspartate receptors J. Biol. Chem. 278 2003 33364 33369
43. M.J. Berridge Neuronal calcium signaling Neuron 21 1998 13 26
44. T. Furuichi, K. Kohda, A. Miyawaki, and K. Mikoshiba Intracellular channels Curr. Opin. Neurobiol. 4 1994 294 303
45. M. Matsumoto, T. Nakagawa, T. Inoue, E. Nagata, K. Tanaka, H. Takano, O. Minowa, J. Kuno, S. Sakakibara, M. Yamada, H. Yoneshima, A. Miyawaki, Y. Fukuuchi, T. Furuichi, H. Okano, K. Mikoshiba, and T. Noda Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor Nature 379 1996 168 171
46. V.A. Street, M.M. Bosma, V.P. Demas, M.R. Regan, D.D. Lin, L.C. Robinson, W.S. Agnew, and B.L. Tempel The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse J. Neurosci. 17 1997 635 645
47. T.-S. Tang, H. Tu, E.Y. Chan, A. Maximov, Z. Wang, C.L. Wellington, M.R. Hayden, I. Bezprozvanny, and Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1 Neuron 39 2003 227 239
48. L. Mao, and J.Q. Wang Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons Brain Res. Mol. Brain Res. 86 2001 125 137
49. L. Mao, and J.Q. Wang Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors Mol. Pharmacol. 62 2002 473 484
50. S.J. Tallaksen-Greene, K.W. Kaatz, C. Romano, and R.L. Albin Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons Brain Res. 780 1998 210 217
51. J.A. Kerner, D.G. Standaert, J.B. Penney Jr., A.B. Young, and G.B. Landwehrmeyer Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus Brain Res. Mol. Brain Res. 48 1997 259 269
52. C.M. Testa, D.G. Standaert, G.B. Landwehrmeyer, J.B. Penney Jr., and A.B. Young Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons J. Comp. Neurol. 354 1995 241 252
53. A.J. Cross, T.J. Crow, J.A. Johnson, J.M. Dawson, and T.J. Peters Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia J. Neurol. Sci. 71 1985 137 143
54. D.W. Choi Calcium: still center-stage in hypoxic-ischemic neuronal death Trends Neurosci. 18 1995 58 60
55. S. Orrenius, B. Zhivotovsky, and P. Nicotera Regulation of cell death: the calcium-apoptosis link Nat. Rev. Mol. Cell Biol. 4 2003 552 565
56. G. Hajnoczky, E. Davies, and M. Madesh Calcium signaling and apoptosis Biochem. Biophys. Res. Commun. 304 2003 445 454
57. R. Rizzuto, P. Pinton, D. Ferrari, M. Chami, G. Szabadkai, P.J. Magalhaes, F. Di Virgilio, and T. Pozzan Calcium and apoptosis: facts and hypotheses Oncogene 22 2003 8619 8627
58. E.J. Slow, J. van Raamsdonk, D. Rogers, S.H. Coleman, R.K. Graham, Y. Deng, R. Oh, N. Bissada, S.M. Hossain, Y.Z. Yang, X.J. Li, E.M. Simpson, C.A. Gutekunst, B.R. Leavitt, and M.R. Hayden Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease Hum. Mol. Genet. 12 2003 1555 1567
59. J.F. Gusella, and M.E. MacDonald Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease Nat. Rev. Neurosci. 1 2000 109 115
60. H.Y. Zoghbi, and H.T. Orr Glutamine repeats and neurodegeneration Annu. Rev. Neurosci. 23 2000 217 247
61. C.J. Cummings, and H.Y. Zoghbi Trinucleotide repeats: mechanisms and pathophysiology Annu. Rev. Genomics Hum. Genet. 1 2000 281 328